Monday, August 24, 2020 3:58:48 PM
From Yahoo.
This is interesting because I have heard they are 24/7 so they must have figured out the supply chain issues they were having. If the above is true, and I am not sure it is, that would put revenue at $200,000 a day just from CoVid testing. I believe they are running 3 shifts. Even if they are doing half that volume it is $100,000 a day!
The next quarterly should be very interesting. Testing should be at capacity. Oncology tests should be back. What will be interesting is how much profit they actually make on testing, hopefully, they don't load expenses.
Speaking of raising capital, anyone find it interesting that the stock is down 40% after Maxim put a $2.00 target on the PPS.
Recent BIOCQ News
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 11/20/2023 01:47:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM